Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Methotrexate gives durable remission from idiopathic granulomatous mastitis

Key clinical point: Methotrexate, in combination with prednisone, might be emerging as the go-to option for idiopathic granulomatous mastitis.

Major finding: Reported remission rates range from 75%-100%.

Study details: A single-center review of 23 patients

Disclosures: There was no external funding, and the investigators didn’t report any disclosures.


Ringsted S et al. Arthritis Rheumatol. 2019;71(suppl 10), Abstract 386.